Smith & Nephew (SNN) Total Non-Current Liabilities (2009 - 2025)
Smith & Nephew (SNN) reported Total Non-Current Liabilities of $3.6 billion for Q4 2025, little changed on a YoY basis from $3.6 billion in Q4 2024, and down 29.42% quarter-over-quarter from $5.1 billion in Q2 2025.
Smith & Nephew (SNN) Total Non-Current Liabilities (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Total Non-Current Liabilities for 17 years, with the latest figure at $3.6 billion in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities changed 0.42% year-over-year to $3.6 billion; the trailing twelve-month figure through Dec 2025 stood at $3.6 billion (changed 0.42% YoY), and the FY2025 full-year result was $3.6 billion, changed 0.42% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $3.6 billion, down from $5.1 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $5.2 billion in Q2 2024, with the low at $2.5 billion in Q4 2023.
- Historically, Total Non-Current Liabilities has averaged $3.7 billion across 5 years, with a median of $3.6 billion in 2024.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities decreased 20.37% — and 2024, when it soared 42.38%.
- Smith & Nephew's Total Non-Current Liabilities stood at $3.2 billion in 2021, then dropped by 7.11% to $3.0 billion in 2022, then slipped by 16.48% to $2.5 billion in 2023, then jumped by 42.38% to $3.6 billion in 2024, then grew by 0.42% to $3.6 billion in 2025.
- The last three Total Non-Current Liabilities figures came in at $3.6 billion (Q4 2025), $5.1 billion (Q2 2025), and $3.6 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | 3.57 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.57 Bn |
| Jun 28, 2025 | 5.06 Bn |
| Dec 31, 2024 | 3.56 Bn |
| Jun 29, 2024 | 5.19 Bn |
| Dec 31, 2023 | 2.50 Bn |
| Dec 31, 2022 | 2.99 Bn |
| Dec 31, 2021 | 3.22 Bn |
| Dec 31, 2020 | 4.05 Bn |
| Jun 30, 2020 | 4.34 Bn |
| Dec 31, 2019 | 2.59 Bn |
| Jun 29, 2019 | 3.85 Bn |
| Dec 31, 2018 | 1.72 Bn |
| Jun 30, 2018 | 2.93 Bn |
| Dec 31, 2017 | 1.88 Bn |
| Dec 31, 2016 | 2.04 Bn |
| Dec 31, 2015 | 1.86 Bn |
| Jun 30, 2015 | 1.94 Bn |
| Dec 31, 2014 | 2.10 Bn |
| Sep 30, 2014 | 3.55 Bn |
| Jun 28, 2014 | 2.44 Bn |